dr. motzer on the milestone of immunotherapy in rcc
Published 7 years ago • 469 plays • Length 1:11Download video MP4
Download video MP3
Similar videos
-
1:10
dr. motzer on first-line treatment of metastatic rcc
-
1:28
dr. motzer on the tivo-3 trial examining tivozanib in advanced rcc
-
1:24
dr. motzer on the tivo-1 trial with tivozanib in advanced rcc
-
1:08
dr. motzer on nivolumab/ipilimumab activity in rcc
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
0:53
dr. jonasch on the potential of immunotherapy for sarcomatoid rcc
-
1:02
dr. choueiri on the research with immunotherapy in rcc
-
1:26
dr. harshman on earlier use of immunotherapy in rcc
-
4:34
immunotherapy in renal cell carcinoma
-
1:25
dr. motzer discusses nivolumab for mrcc
-
1:33
dr. mcdermott on single-agent nivolumab in rcc
-
1:57
dr. motzer on nivolumab versus everolimus in renal call carcinoma
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
1:15
dr. mcdermott on single-agent versus combination immunotherapy in rcc
-
1:19
dr. clark on the potential of immunotherapy in renal cell carcinoma
-
1:23
dr. lee on immunotherapy's future in rcc
-
0:53
dr. figlin on advances in immunotherapy for kidney cancer
-
2:16
dr. rini on axitinib for treatment of metastatic renal cell carcinoma
-
8:43
immunotherapy in renal cell carcinoma